ams-OSRAM Valuation
Is AMS1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AMS1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AMS1 (CHF10.87) is trading below our estimate of fair value (CHF41.6)
Significantly Below Fair Value: AMS1 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AMS1?
Other financial metrics that can be useful for relative valuation.
| What is AMS1's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | €1.14b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | 3.6x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does AMS1's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.9x | ||
UBXN u-blox Holding | 1.6x | 16.7% | CHF 581.6m |
MBTN Meyer Burger Technology | 0.4x | 28.1% | CHF 49.2m |
WIHN WISeKey International Holding | 0.7x | 30.2% | CHF 12.3m |
600206 Grinm Advanced Materials | 0.9x | 11.0% | CN¥9.2b |
AMS1 ams-OSRAM | 0.3x | 6.4% | CHF 1.1b |
Price-To-Sales vs Peers: AMS1 is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.9x).
Price to Earnings Ratio vs Industry
How does AMS1's PE Ratio compare vs other companies in the European Semiconductor Industry?
Price-To-Sales vs Industry: AMS1 is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Semiconductor industry average (2.1x).
Price to Sales Ratio vs Fair Ratio
What is AMS1's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | 0.6x |
Price-To-Sales vs Fair Ratio: AMS1 is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 10.87 | CHF 16.54 +52.2% | 26.9% | CHF 25.14 | CHF 11.63 | n/a | 9 |
| Sep ’25 | CHF 10.44 | CHF 16.41 +57.2% | 29.1% | CHF 25.24 | CHF 11.45 | n/a | 9 |
| Aug ’25 | CHF 11.80 | CHF 17.37 +47.3% | 30.0% | CHF 25.70 | CHF 11.61 | n/a | 10 |
| Jul ’25 | CHF 12.47 | CHF 17.52 +40.5% | 29.3% | CHF 25.69 | CHF 10.55 | n/a | 10 |
| Jun ’25 | CHF 14.40 | CHF 17.99 +24.9% | 29.3% | CHF 26.28 | CHF 10.79 | n/a | 10 |
| May ’25 | CHF 11.17 | CHF 32.91 +194.8% | 141.9% | CHF 179.80 | CHF 10.81 | n/a | 11 |
| Apr ’25 | CHF 10.48 | CHF 35.76 +241.4% | 127.7% | CHF 179.16 | CHF 14.31 | n/a | 11 |
| Mar ’25 | CHF 13.22 | CHF 33.93 +156.7% | 126.4% | CHF 175.12 | CHF 13.98 | n/a | 12 |
| Feb ’25 | CHF 20.30 | CHF 48.41 +138.5% | 97.0% | CHF 170.57 | CHF 17.32 | n/a | 10 |
| Jan ’25 | CHF 21.14 | CHF 55.66 +163.3% | 88.6% | CHF 174.30 | CHF 17.08 | n/a | 9 |
| Dec ’24 | CHF 16.09 | CHF 61.73 +283.7% | 73.4% | CHF 172.98 | CHF 16.95 | n/a | 9 |
| Nov ’24 | CHF 32.23 | CHF 75.23 +133.4% | 59.1% | CHF 175.52 | CHF 32.40 | n/a | 10 |
| Oct ’24 | CHF 43.16 | CHF 76.86 +78.1% | 49.8% | CHF 164.92 | CHF 39.98 | CHF 11.30 | 11 |
| Sep ’24 | CHF 62.60 | CHF 82.69 +32.1% | 38.4% | CHF 165.20 | CHF 48.31 | CHF 10.44 | 13 |
| Aug ’24 | CHF 77.28 | CHF 83.50 +8.0% | 39.7% | CHF 165.70 | CHF 48.74 | CHF 11.80 | 12 |
| Jul ’24 | CHF 64.42 | CHF 77.67 +20.6% | 44.1% | CHF 166.93 | CHF 49.81 | CHF 12.47 | 13 |
| Jun ’24 | CHF 67.54 | CHF 77.45 +14.7% | 44.0% | CHF 166.44 | CHF 49.66 | CHF 14.40 | 13 |
| May ’24 | CHF 61.40 | CHF 86.94 +41.6% | 40.6% | CHF 169.43 | CHF 55.75 | CHF 11.17 | 13 |
| Apr ’24 | CHF 70.82 | CHF 87.46 +23.5% | 40.8% | CHF 170.64 | CHF 56.14 | CHF 10.48 | 13 |
| Mar ’24 | CHF 73.04 | CHF 87.91 +20.4% | 38.3% | CHF 165.48 | CHF 55.80 | CHF 13.22 | 13 |
| Feb ’24 | CHF 91.22 | CHF 90.95 -0.3% | 41.8% | CHF 179.88 | CHF 59.96 | CHF 20.30 | 13 |
| Jan ’24 | CHF 67.50 | CHF 92.37 +36.8% | 41.9% | CHF 179.48 | CHF 59.83 | CHF 21.14 | 12 |
| Dec ’23 | CHF 79.02 | CHF 90.81 +14.9% | 43.8% | CHF 179.26 | CHF 52.84 | CHF 16.09 | 12 |
| Nov ’23 | CHF 58.16 | CHF 100.20 +72.3% | 39.4% | CHF 193.40 | CHF 53.07 | CHF 32.23 | 12 |
| Oct ’23 | CHF 62.46 | CHF 102.14 +63.5% | 35.2% | CHF 187.44 | CHF 68.84 | CHF 43.16 | 11 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.